LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 211,600 shares, a drop of 34.3% from the March 15th total of 322,100 shares. Currently, 1.5% of the company’s stock are sold short. Based on an average daily volume of […]